Latuda and Ubrelvy drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Latuda (lurasidone hydrochloride) and Ubrelvy (ubrogepant). Common drug interactions include fatigue among females and anxiety among males.

The phase IV clinical study analyzes what interactions people have when they take Latuda and Ubrelvy. It is created by eHealthMe based on reports of 16 people who take the same drugs from the FDA, and is updated regularly.

What is Latuda?

Latuda has active ingredients of lurasidone hydrochloride. It is often used in bipolar disorder. eHealthMe is studying from 21,543 Latuda users. Check the latest studies of Latuda.

What is Ubrelvy?

Ubrelvy has active ingredients of ubrogepant. eHealthMe is studying from 3,585 Ubrelvy users. Check the latest studies of Ubrelvy.

On Jul, 11, 2026

16 people who take Latuda and Ubrelvy together, and have interactions are studied.

What are the common drug interactions of Latuda and Ubrelvy, by gender? *:

female:

Fatigue (feeling of tiredness)
Headache (pain in head)
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development)
Arthralgia (joint pain)
Back pain
Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
Cystic fibrosis (disease of the secretary glands)
Dyspnoea (difficult or laboured respiration)
Joint stiffness
Joint swelling

male:

Anxiety
Arthritis (form of joint disorder that involves inflammation of one or more joints)
Neuropathy peripheral (surface nerve damage)
Diarrhoea
Dysuria (painful or difficult urination)
Ejaculation disorder
Hallucination (an experience involving the perception of something not present)
Hypersensitivity
Immunodeficiency
Irritable bowel syndrome

What are the common drug interactions of Latuda and Ubrelvy, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Epistaxis (bleed from the nose)

30-39:

Obstructive sleep apnoea syndrome (frequent pauses in breathing during sleep usually accompanied by loud snoring)

40-49:

Fatigue (feeling of tiredness)
Joint swelling
Speech disorder
Asthma
Fungal infection
Injection site erythema (redness at injection site)
Injection site pruritus (severe itching at injection site)
Injection site rash
Injection site swelling
Pain

50-59:

n/a

60+:

Neutropenia (an abnormally low number of neutrophils)

What are the existing conditions these people have? *

Ankylosing Spondylitis (type of arthritis affecting the spine): 6 people, 37.50%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 4 people, 25.00%
Spondyloarthropathy (any joint disease of the vertebral column): 3 people, 18.75%
Migraine (headache): 3 people, 18.75%
Thyroid Diseases: 2 people, 12.50%
Asthma: 2 people, 12.50%
Idiopathic Urticaria (allergic reactions, presence of hives with unknown cause): 2 people, 12.50%
Dermatitis Atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder): 2 people, 12.50%
Diabetes: 2 people, 12.50%
Dry Eyes (lack of adequate tears): 1 person, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Latuda and Ubrelvy?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously